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Purpose: Lipid nanospheres are used for the passive targeting of cosmetic agents to skin, 
thereby achieving major benefits such as reduction of total dose and avoidance of systemic 
absorption.  The present study was carried out to exploit the feasibility of using polymeric 
nanospheres as an alternative and cheaper carrier for targeting corticosteroids to the skin. 
Methods: Nanospheres were prepared from ethyl cellulose by a modified method of 
desolvation and cross linking.  The drug betamethazone was incorporated into nanospheres 
and the drug: polymer ratio was evaluated to determine the carrier capacity of the polymer. In 
vitro release studies of drug-loaded nanospheres were carried out by the centrifugal 
ultrafiltration method.  The kinetics of release was determined and fitted to an empirical 
equation.  The release of drug from drug-loaded nanospheres dispersing in a conventional 
cream was evaluated.  A comparative in vitro diffusion study was carried out between a 
commercial brand of cream and the cream incorporating nanospheres. 
Results: Formulation of nanospheres of betamethazone by a modified method produced 
discrete particles. Studies on drug:polymer ratio showed a linear relationship between drug 
concentration and percentage of loading. The in vitro release of drug-loaded nanospheres 
was found to be first order.  The comparative in vitro diffusion study between the commercial 
cream and the formulated cream showed a marked reduction in release rate from 
nanospheres-bound cream. 
Conclusion: Formulated topical cream containing nanospheres of betamethazone was found 
to be a potential dermal delivery system for sustaining the release of the drug. 
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Introduction 
 
In recent years, there has been a considerable 
interest in the development of novel drug 
delivery systems in order to modify and control 
pharmacokinetic behavior of the drugs. By 
incorporation into a carrier system, it is possible 
to alter the therapeutic index and duration of 
activity of drugs1.  Colloidal drug delivery system 
represents one of the frontiers of science, which 
offers numerous advantages such as improved 
efficiency, reduced toxicity and improved patient 
compliance over conventional dosage forms. 
Nanoparticles are colloidal drug delivery systems 
that offer site-specific as well as controlled drug 
delivery2-4. Many of the conventional vehicles 
such as creams, ointments requires high 
concentration of active ingredients for effective 
therapy due to their low efficiency as delivery 
systems5.  Over the past decade, particulate 
carriers such as liposomes and microspheres 
have been investigated for the delivery of drugs 
to specific skin compartments in order to control 
drug input, release, retention and action in/into 
the skin and also to reduce systemic absorption 
and consequently adverse reactions. In vitro and 
in vivo experiments proved particulate carriers to 
be worthwhile for increasing cutaneous 
bioavailability and decreasing systemic 
absorption of many drugs6. The topical 
bioavailability of 5-aminolevulinic acid was 
improved when loaded into liposomes7. 
Incorporation of corticosteroids in liposomes 
provided a higher concentration and efficient 
delivery of corticosteroids.8-9 Hence, in the 
present study, an attempt has been made to 
formulate ethyl cellulose nanospheres containing 
betamethazone, which may provide prolonged 
drug delivery in the treatment of inflammation 
and also minimize side effects such as pruritis, 






Betamethazone (Glaxo SmithKline 
Pharmaceuticals Ltd), Ethyl cellulose (Sigma), 
Tripolyidine phosphate (Sigma Chemicals), 
dialysis membrane (Sigma Chemicals), sodium 
hydroxide (LR grade), linseed oil (commercial 
grade), Tween 80 (LR grade, SD Fine 
Chemicals), toluene and potassium dihydrogen 
phosphate (LR grade, S.D Fine Chemicals) and 




Preparation of betamethazone nanospheres by 
desolvation and crosslinking method10 and study 
on drug : polymer ratio 
 
An ethanolic solution (50 ml) containing 
betamethazone 6.25 mg, ethyl cellulose (1% 
w/v) and Tween 80 (1% w/v) was desolvated by 
stirring at 200 rpm at 30±1 ºC using distilled 
water.  The extent of desolvation was monitored 
by visually by its turbid appearance and through 
optical microscopy. By trial and error method, it 
was determined that for every 50 ml of ethanolic 
solutions of ethyl cellulose, a minimum of 12 ml 
of water is required for desolvation. Tripolydine 
phosphate (10 ml of 15%) was added slowly to 
the suspension and stirred and continuously for 
1 hr. The resultant turbid dispersion was dried at 
30±1 ºC on a glass plate. Ethyl cellulose 
nanospheres, along with the impurities, were 
obtained as a powder mass. Water (5 ml) was 
added and centrifuged at 5000 rpm for 10 min. 
After washing with water, the nanospheres were 
collected in the supernatant layer as a thin ring-
like structure, filtered and dried.  Following this 
procedure, four other batches of ethyl cellulose 
nanospheres with varying concentrations of 
betamethazone - 12.5, 18.8, 25 and 50 mg - 
were prepared and coded batch B,C,D and E. 
For the determination of drug loading in each 
batch only the concentration of the drug was 
varied but other processing variables were kept 
constant. 
 
Estimation of amount of drug incorporated into 
ethyl cellulose nanospheres 
 
A quantity of drug-loaded nanospheres 
equivalent to 20 mg of drug from each batch 
placed in a mortar, 10 ml ethanol was added and 
triturated to crush the nanoparticles. This 
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solution was then centrifuged and the drug 
content of the supernatant solution was analyzed 
by UV spectrophotometry at 267.6 nm. 
 





Fig 1: Transmission electron micrograph of
ethyl cellulose nanospheres containing
betamethazone 
The size and shape of the particles were also 
examined using TEM (Jeol EX 12, Japan). The 
specimens were prepared by dropping a mixture 
of phosphotungstic acid a dilute suspension of 
the nanospheres on EM grids (Formvar filmed, 
G200 mesh, Bio Rad, UK). Each grid was held 
for 20 s horizontally and then 45 0C to allow 
excess fluid to drain. The specimens were air 
dried before examination with an electron 
microscope. The electron microscopic view of 
nanospheres containing betamethazone is 
shown in Fig 1. 
 
In vitro release of drug loaded nanospheres 
before incorporating into cream base12-13
 
A quantity of nanospheres equivalent to 20mg of 
drug from each batch was placed in a 250 ml 
conical flask and to it 20ml ethanol and 80 ml 
phosphate buffer pH 7.4 were added. The flask 
was kept in a shaker incubator with the shaker 
oscillating at 20/min at 37 oC. 5ml of drug 
release medium was withdrawn at various time 
intervals over a 24 h period. The samples were 
filtered and the drug content was analyzed by 
UV spectrophotometry at 267.6 nm.  
 
Invitro release of drug-loaded nanospheres after 
incorporation into cream 
 
10mg of drug-loaded nanospheres from each 
batch ‘D’ were placed in 250 ml conical flask, 
and 10 ml of ethanol and 90 ml of phosphate 
buffer saline (PH 7.4) was added to it. The flask 
was kept in a shaker incubator oscillating at 
20/min at 37 ± 1ºC. 5ml of drug release medium 
was withdrawn at various time intervals over a 
24 h period. These samples were vaccum-
filtered through a membrane of 1µm pore size.  
The drug content was determined 
spectrophotometrically at 267.6 nm.  
 
Formulation of conventional cream and 
dispersion of drug loaded nanospheres in cream 
 
Preparation of creams: Oil soluble ingredients 
from the formula were first dissolved in the oil 
phase and the water soluble ingredients were 
dissolved in the aqueous phase. Both the 
phases were prepared separately and heated to 
a temperature of 70 oC separately. The oil phase 
was slowly incorporated into the aqueous phase 
by vigorous stirring until the formation of cream 
was smooth and uniform. The formulated 
cream was investigated for its physical 
parameters like consistency, homogenicity, 
spreadability, washability and extrudability. 
 
 
Table1: Formula for preparing creams  
Ingredient For 100 g 
(w/w) 




Preservative 1 g 
Perfume q.s 
Water 80mL Trop J Pharm Res, December 2005; 4 (2) 497
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Dispersion of drug loaded nanospheres into 
the cream base: A specific quantity of 
nanospheres from batch ‘D’ equivalent to 1mg of 
drug was incorporated into the selected cream 
base by simple mixing.  
 
The medicated creams were then subjected to 
invitro diffusion studies. Three such sample 
batches were studied for their in vitro release 
characteristics. 
 
In vitro diffusion studies of the cream 
containing dispersed nanospheres: Release 
of the drug, betamethazone, from the 
medicated creams was studied employing the 
permeation apparatus designed and described 
by Fites et al14. A glass cylinder with both ends 
open (10 cm high 3.7 cm outer diameter) was 
used as the permeation cell. A dialysis tubing 
(Sigma) soaked in a mixture glycerin and water 
(1:1) for 2 hr before use was fixed to one end of 
the cylinder with the aid of an adhesive 
resulting in a permeation cell. The medicated 
cream (1 g) was placed in the cell (donor 
compartment) and the cell was immersed in a 
250 ml beaker containing drug-free diffusion 
medium, i.e., a mixture of 20 ml of ethanol and 
180 ml 7.4 pH phosphate buffer; which served 
as the receptor compartment. The cell was 
immersed to a depth of 1 cm below the surface 
of water in the receptor compartment. The 
medium in the receptor compartment was 
agitated using a magnetic stirrer at 37oC ± 1oC. 
A sample (5ml) of the receptor compartment fluid 
was taken at various intervals of time over a 
period of 24 h and analyzed for drug content at 
267.6 nm. The volume withdrawn each time was 
replaced with drug-free receptor fluid. The 
amount of drug released at various intervals of 
time was calculated and plotted against time as 
shown in Fig 2. This procedure was repeated for 
the conventional cream (Betnovate cream 
betamethazone 0.1% w/w). The experiment was 
carried out in triplicate, and the mean cumulative 
percentage release from three batches was 
calculated.   
 
 
Results and Discussion 
 
The nanospheres prepared by desolvation and 
crosslinking method were found to have discrete 
particle size and shape within the size range of 
703±11 nm. The TEM of the drug-loaded 
nanospheres is shown Fig.1.  There was a linear 
relationship between concentration of drug and 
percentage of loading up to a particular 
concentration (25mg/mg polymer).  A decrease 
in drug loading was observed after that point due 
to the saturation capacity of polymer.  The drug 
loading capacity of different batches are shown 
in Table 2. The drug loading was found to be 
23.9±1.8%, 36.9±1.1%, 62.4±2.0%, 74.0±0.2% 
and 20.9±1.4% respectively for batches A, B, C, 
D and E. In order to predict and correlate the 
release behavior of drugs from matrix, it is 
necessary to fit the data into a suitable model. 
The percentage of release from the drug-loaded 
nanospheres was in the range of 74 to 96%. The 
in vitro release profile of betamethazone from all 
the formulated batches are shown in Fig 2. 
Hence, the dissolution data were fitted according 
to the well known exponential equation,15 which 
is often used to describe drug release behavior 








0 5 10 15 20 25
Figure 2: Invitro release profile of ethyl cellulose 
nanospheres containing various concentrations 
of betamethazone. Batch A (■), Batch B (♦), 
Batch C (▲), Batch D (●) and Batch E (▬).  
Mt/M∞ = Ktn   
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where, Mt/M∞ is the fractional release of the 
drug,‘t’ is the release time, ‘k’ is a constant which 
incorporated the properties of the 
macromolecular polymeric system and ‘n’ is the 
release exponent indicative of the mechanism of 
release. The ‘n’ value used for analysis of the 
drug release mechanism from the nanospheres 
was determined from log (Mt/M∞) Vs log(t) plots. 
To calculate the release constant ‘k’, the 
logarithm of the remaining betamethazone in 
nanospheres is plotted versus time. The 
betamethazone nanospheres followed 1st order 
release over the period.  In Table 3, the values 
of ‘k’, ‘n’ and ‘r’ for five different batches as 
reported, and the ‘n’ values were within 0.5122 
to 0.5399, and the ‘n’ value for the nanospheres 
bound cream was also 0.5272.  Thus the release 
mechanism is based on Fickian diffusion for both 
the nanospheres and the nanosphere bound 
cream. Among the different batches of drug 
loaded nanospheres, batch ’D’ (prepared with 25 
mg of drug/mg polymer) was found to possess a 
comparatively better and higher drug loading 
capacity.  Therefore, batch ‘C’ was subjected to 
TEM analysis and size of drug loaded 
nanospheres were found to be slightly higher 

























Figure 3: Comparative in vitro drug release from 
conventional cream (■) and nanosphere-
incorporated cream (♦) by dialysis method
 
 











Drug loading capacity (%) 
± SD 
1 Batch ‘A’ 6.25 23.95±1.8 
2 Batch ‘B’ 12.5 36.95±1.1 
3 Batch ‘C’ 18.8 62.44±2.0 
4 Batch ‘D’ 25 73.99±0.2 
5 Batch ‘E’ 50 20.91±1.4 
 
 
Table 3: Invitro release kinetics of drug-loaded nanospheres 
 















Batch ‘A’ 6.25 0.0545 0.9947 0.5383 0.9225 
Batch ‘B’ 12.5 0.0469 0.9972 0.5389 0.9347 
Batch ‘C’ 18.8 0.0713 0.9789 0.5337 0.9304 
Batch ‘D’ 25 0.0794 0.9833 0.5123 0.9031 
Batch ‘E’ 50 0.0849 0.9924 0.5122 0.9065 
Nanosphere- 
bound cream 
 0.0499 0.9993 0.5272 0.9955 
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batches of nanospheres containing 
betamethazone, batch ‘D’ prepared with 25 mg 
drug was incorporated into the cream.  To 
compare the invitro release profile of 
betamethazone from nanospheres after 
incorporation into the cream with that of drug 
release from conventional cream comparative 
invitro diffusion study was carried out using 
phosphate buffer PH 7.4 containing 10% ethanol 
by dialysis method for 24 h.  The study revealed 
that the release of betamethazone from the 
conventional cream was found to be faster than 
from nanosphere bound cream. The cumulative 
release of drug from conventional cream at the 
6th hour was 57%, while it was only 28% for the 
formulated cream. The T50% of the drug was 
found to be 3 and 11 h, for the conventional and 
nanosphere-incorporated creams, respectively. 
The comparative invitro results obtained using 
the dialysis method are depicted in Fig 3. Thus, 
the formulated cream containing nanospheres 
exhibited sustained release over a period of 24 
h. Indicating that the dispersion of nanospheres 
in the cream base had a retarding effect on the 




Formulation and evaluation of a topical drug 
delivery system containing betamethazone 
loaded nanospheres was found to be a potential 
and cost effective and sustained dermal delivery 
system in terms of particle size distribution, 
optimum drug loading capacity, and invitro 
diffusion characteristics.  The system induced 
prolonged drug release and could, therefore, 
produce some benefits such as reduction in total 
dose, frequency of administration, and dose -
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